Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OXTR | P30559 | 3/20 | 0.46 |
| ▸ | AVPR1A | P37288 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | IL2 | P60568 | 1/20 | 0.38 |
| ▸ | CTSA | P10619 | 1/20 | 0.37 |
| ▸ | PDCD1 | Q15116 | 2/20 | 0.37 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31743315 | 0.77 | OXTR (0.56) | OXTRAVPR1AMAPK1MAPTPDCD1 | |
| SCHEMBL31156141 | 0.77 | OXTR (0.56) | OXTRAVPR1AMAPK1MAPTPDCD1 | |
| SCHEMBL15539723 | 0.75 | GABRP (0.46) | OXTRAVPR1AMAPK1 | |
| SCHEMBL931505 | 0.72 | OXTR (0.59) | OXTRAVPR1AMAPK1NPC1SMN1; SMN2 | |
| SCHEMBL15539482 | 0.72 | SCN9A (0.46) | — | |
| SCHEMBL21906524 | 0.71 | RXRB (0.43) | MAPK1NPC1SMN1; SMN2MAPT | |
| SCHEMBL25213243 | 0.71 | MEN1 (0.49) | MAPK1SMN1; SMN2MAPTALDH1A1GAA | |
| SCHEMBL68869 | 0.71 | MAPK1 (0.63) | MAPK1MAPTALDH1A1 | |
| SCHEMBL31444382 | 0.71 | PDCD1 (0.48) | OXTRAVPR1AMAPK1NPC1CTSA | |
| SCHEMBL15539481 | 0.69 | P4HTM (0.46) | NPC1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025072451-A1 | RAS-PI3K INHIBITORS FOR THE TREATMENT OF CANCER AND IMMUNOLOGICAL DISEASES | VIVIDION THERAPEUTICS, INC. (US) | 2025-04-03 | — | — | WO | disclosed |